Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua F Apgar

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
CPT: Pharmacometrics & Systems Pharmacology|May 25, 2024
Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitorsSarah A Head, Carter Johnson, Saheli Sarkar, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2021
Virtual clinical trial simulations for a novel KRAS<sup>G12C</sup> inhibitor (ASP2453) in non-small cell lung cancerHiroyuki Sayama, Diana Marcantonio, Takeyuki Nagashima, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 14, 2022
Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloidLin Lin, Fei Hua, Cristian Salinas, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 4, 2026
Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-AnalysisCarter L Johnson, Deborah A Flusberg, Sarah A Head, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 22, 2019
A quantitative systems pharmacology model of colonic motility with applications in drug developmentRaibatak Das, Lucia Wille, Liming Zhang, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2021
A systems pharmacology model for gene therapy in sickle cell diseaseBo Zheng, Lucia Wille, Karsten Peppel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2021
Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's diseaseKumpal Madrasi, Raibatak Das, Hafiz Mohmmadabdul, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2018
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1Joshua F Apgar, Jian-Ping Tang, Pratap Singh, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
CPT: Pharmacometrics & Systems Pharmacology|May 25, 2024
Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitorsSarah A Head, Carter Johnson, Saheli Sarkar, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2021
Virtual clinical trial simulations for a novel KRAS<sup>G12C</sup> inhibitor (ASP2453) in non-small cell lung cancerHiroyuki Sayama, Diana Marcantonio, Takeyuki Nagashima, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 14, 2022
Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloidLin Lin, Fei Hua, Cristian Salinas, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 4, 2026
Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-AnalysisCarter L Johnson, Deborah A Flusberg, Sarah A Head, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 22, 2019
A quantitative systems pharmacology model of colonic motility with applications in drug developmentRaibatak Das, Lucia Wille, Liming Zhang, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2021
A systems pharmacology model for gene therapy in sickle cell diseaseBo Zheng, Lucia Wille, Karsten Peppel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2021
Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's diseaseKumpal Madrasi, Raibatak Das, Hafiz Mohmmadabdul, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2018
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1Joshua F Apgar, Jian-Ping Tang, Pratap Singh, et al.
Pageof 2